Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
4.98M
-
Shares change
-
+594K
-
Total reported value, excl. options
-
$19.1M
-
Value change
-
+$2.28M
-
Number of buys
-
19
-
Number of sells
-
-24
-
Price
-
$3.84
Significant Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q3 2020
51 filings reported holding ORGO - Organogenesis Holdings Inc. - Common Stock, $0.01 par value as of Q3 2020.
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.98M shares
of 127M outstanding shares and own 3.92% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.06M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (752K shares), Prosight Management, LP (677K shares), GEODE CAPITAL MANAGEMENT, LLC (380K shares), VANGUARD GROUP INC (298K shares), NORTHERN TRUST CORP (269K shares), STATE STREET CORP (259K shares), RENAISSANCE TECHNOLOGIES LLC (192K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (166K shares), and BANK OF MONTREAL /CAN/ (121K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.